Search Login Register

SHU 508 (Levovist) Summary

197 relevant articles (21 outcomes, 43 trials/studies) found for this Bio-Agent

Description: intravenous saccharide echo contrast agent with transpulmonary capacity for left heart contrast; appears in Japanese literature as SH/TA-508

Also Known As: Levovist; SH-TA-508; SHU 508 A; SHU-508

Key Diseases for which SHU 508 is Relevant

  1. Neoplasms (Cancer) : 4 outcomes 8 studies in 47 results
  2. Hepatocellular Carcinoma (Hepatoma) : 3 outcomes 10 studies in 34 results
  3. Neoplasm Metastasis (Metastasis) : 3 outcomes 2 studies in 16 results
  4. Mitral Valve Insufficiency (Mitral Regurgitation) : 2 outcomes in 2 results
  5. Carcinoma (Carcinomatosis) : 1 outcome 2 studies in 12 results
Show All >>

Drugs Related to SHU 508

  1. Colloids (Colloid)
  2. Contrast Media
  3. glucuronyl glucosamine glycan sulfate (Vessel)
  4. Galactose (Galactopyranose)
  5. Ethanol (Ethyl Alcohol)
  6. 3-chloro-4,4-dimethyl-2-oxazolidinone (agent I)
  7. FS 069 (Optison)
  8. contrast agent BR1
  9. SHU 508 (Levovist)
  10. Palmitic Acid (Hexadecanoic Acid)
Show All >>

Therapies Related to SHU 508

  1. Microbubbles
  2. Infusion Pumps (Infusion Pump)
  3. Transplants (Transplant)
  4. Laparotomy
  5. Drug Therapy (Chemotherapy)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.